Min Ruan Selected Research

B-Lymphocyte Differentiation Antigens (Antigens, Differentiation, B Lymphocyte)

4/2012

[An unusual child case of myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Ruan Research Topics

Disease

13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2009
13	Neoplasms (Cancer) 01/2022 - 02/2010
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2021 - 03/2014
8	Squamous Cell Carcinoma of Head and Neck 01/2022 - 02/2010
5	Infections 01/2022 - 02/2014
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2022 - 12/2018
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
4	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 06/2012
4	Carcinogenesis 12/2018 - 04/2010
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018 - 03/2015
4	Chromosome Aberrations (Chromosome Abnormalities) 04/2016 - 10/2009
3	Philadelphia Chromosome 02/2021 - 06/2015
3	Leukemia 02/2021 - 04/2012
3	Mouth Neoplasms (Oral Cancer) 01/2018 - 01/2014
2	Hematologic Diseases (Blood Diseases) 09/2021 - 04/2016
2	Lymphatic Metastasis 06/2021 - 01/2016
2	Neutropenia 11/2020 - 04/2018
2	Melanoma (Melanoma, Malignant) 10/2018 - 01/2018
2	Acute Promyelocytic Leukemia 01/2018 - 05/2012
2	Hemorrhage 04/2017 - 07/2015
2	Chromosome Breakage 08/2016 - 02/2013
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 12/2012 - 06/2012
1	Residual Neoplasm 09/2021
1	Multiple Myeloma 01/2021
1	Febrile Neutropenia 11/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2020
1	Hyperthermia 11/2018
1	Sepsis (Septicemia) 01/2018
1	Thrombocytopenia (Thrombopenia) 07/2015
1	Cytopenia 07/2015
1	Purpura 03/2015

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2022 - 06/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2015
4	AutoantibodiesIBA 01/2018 - 03/2015
4	Inosine Triphosphate (ITP)IBA 01/2018 - 03/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 06/2014
3	Tyrosine Kinase InhibitorsIBA 02/2021 - 06/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 02/2014
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 04/2012
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019 - 02/2014
3	Messenger RNA (mRNA)IBA 12/2018 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 02/2021 - 10/2014
2	Circular RNAIBA 01/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2018
2	Long Noncoding RNAIBA 01/2021 - 10/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 02/2014
2	Core Binding Factors (Core-Binding Factor)IBA 07/2020 - 05/2020
2	Biological ProductsIBA 09/2019 - 10/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 03/2015
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2016 - 02/2013
1	nidogen (entactin)IBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	MucinsIBA 01/2022
1	VimentinIBA 01/2022
1	OrnidazoleIBA 01/2022
1	DimetridazoleIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	apatinibIBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	pegylated granulocyte colony-stimulating factorIBA 11/2020
1	CD19-specific chimeric antigen receptorIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019
1	Interferon-alpha (Interferon Alfa)IBA 01/2019
1	WortmanninIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 11/2018
1	Microphthalmia-Associated Transcription FactorIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Pemetrexed (MTA)FDA Link 04/2018
1	Competitive Endogenous RNAIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Arsenic Trioxide (Trisenox)FDA Link 01/2018
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 04/2017
1	Complement System Proteins (Complement)IBA 04/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	ZincIBA 02/2016
1	Imatinib Mesylate (Gleevec)FDA Link 08/2015
1	Neuraminidase (Sialidase)IBA 07/2015
1	Dasatinib (BMS 354825)FDA Link 06/2015

Therapy/Procedure

14	Therapeutics 01/2022 - 12/2006
9	Drug Therapy (Chemotherapy) 02/2021 - 10/2009
2	Ligation 04/2016 - 01/2016
1	Hematopoietic Stem Cell Transplantation 02/2021
1	Salvage Therapy 01/2021
1	Induction Chemotherapy 01/2021
1	Length of Stay 11/2020
1	Transplantation 06/2020
1	Radiotherapy 11/2018
1	Immunotherapy 01/2018
1	Neck Dissection (Radical Neck Dissection) 01/2016